U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07122206) titled 'Monitoring the Response of Combination Ursodiol and Seladelpar Treatment' on Aug. 07.
Brief Summary: This study aims to provide comprehensive insights into the therapeutic effects of combination treatment with ursodiol and seladelpar in PBC patients by assessing biochemical responses using biomarkers such as ALP and total bilirubin.
Study Start Date: Aug., 2025
Study Type: OBSERVATIONAL
Condition:
Primary Biliary Cholangitis
Intervention:
PROCEDURE: Blood Draws
Research-related blood draws will be used to ascertain FGF19 levels.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Methodist Health System
Published by HT Digital...